Advanced Vulvar Cancers: What are the Best Options for Treatment?
- 491 Downloads
The treatment of patients with vulvar cancer remains challenging for gynecologic oncologists. Up to 30 % of the cases are diagnosed in a clinical condition of irresectability, and some kind of strategy has to be taken into account beyond surgery. In this regard, a common and standard definition is critical to maximize oncological results and minimize complications after treatments. Each patient treatment must be tailored individually according to their clinical and biological features and to the setting in which they are dealing with.
KeywordsVulvar cancer Neoadjuvant chemotherapy Chemoradiation Radical surgery
To Nicasio Cuneo, a great boss and better friend.
Compliance with Ethics Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 5.Aragona AM, Cuneo NA, Soderini AH. Epidemiology of gynecological cancers. Scientific conference of the Oncology Hospital of Buenos Aires Marie Curie 80th anniversary. Autonomous City of Buenos Aires. 2011.Google Scholar
- 7.Sobin LH, Gospodarowicz MK, Wittekind CH, editors. TNM classification of malignant tumours. 7th ed. Oxford: Wiley- Blackwell; 2009.Google Scholar
- 9.••Aragona AM, Cuneo NA, Soderini AH, Alcoba EB. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol. 2014;132(3):643–8. The concept of a new subgroup of risk, which allows a better stratification for treatment selection, has been introduced by the authors.CrossRefPubMedGoogle Scholar
- 12.Wagenaar HC, Colombo N, Vergote I, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer Gynecol Oncol. 2001;81:348.PubMedGoogle Scholar
- 14.Witteveen PO, Van der Velden J, Vergote I, et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group). Ann Oncol. 2009;20:1511–6. 19.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.••Aragona AM, Cuneo N, Soderini AH, Alcoba E, Greco A, Reyes C, et al. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study. Int J Gynecol Cancer. 2012;22(7):1258–63. The largest prospective study published to date regarding the topic. Neoadjuvant chemotherapy produced a considerable response rate >80% and the 5-year survival rate following surgery was >92%.CrossRefPubMedGoogle Scholar
- 25.••Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally- advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529–33. Pioneering GOG publication as for chemoradiation in vulvar cancer.CrossRefPubMedGoogle Scholar
- 27.Bortolozzi G, Arnoletti E, Belloni C, et al. New integrated therapy in vulvar cancer. Proceedings of International Meeting of Gynecologic Oncology. 1985;420.Google Scholar
- 28.Strzinar V, Kocijan A, Kovacic J, et al. Adriamycin and bleomycin in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Proceedings of International Meeting of Gynecologic Oncology. 1985;408:15Y19.Google Scholar
- 29.Itala J, Belardi G, Sardi J, et al. Poliquimioterapia neoadyuvante en el tratamiento del carcinoma invasor de la vulva. Revista de la Sociedad de Obstetricia y Ginecologı´a de Buenos Aires (SOGIBA). 1986;865:239Y245.Google Scholar
- 36.Sananes C, Giaroli A, Soderini A, Guardado N, Sanaidas L, Bermúdez A, et al. Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cérvix uteri: long-term follow up of a pilot study. Eur J Gynaecol Oncol. 1998;19(4):368–73.PubMedGoogle Scholar
- 38.Tierney J. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Eur J Cancer. 2003;39(17):2470–86. Review.CrossRefGoogle Scholar
- 40.de Vulva C, Azcune. Guias para el diagnóstico, tratamiento y segimiento del cáncer ginecológico.Asociacion Argentina de Ginecología Oncológica. 2013. p. 13–32.Google Scholar